Net Loss per Share - Potentially Dilutive Shares Excluded From Computation Of Diluted Net Income/(Loss) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	96,221,714,000	2,782,560	96,221,714,000	2,782,560
Shares issuable upon conversion of SPA Notes and settlement of make-whole provisions
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	89,569,362,000	1,110,705	89,569,362,000	1,110,705
Shares issuable upon exercise of SPA Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	1,654,726,000	884,681	1,654,726,000	884,681
Other warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	4,096,242,000	17,863	4,096,242,000	17,863
Stock-based compensation awards – Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	428,081,000	473,659	428,081,000	473,659
Stock-based compensation awards – RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	177,650,000	0	177,650,000	0
Public warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	294,263,000	292,200	294,263,000	292,200
Private warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	1,390,000	3,452	1,390,000	3,452